[Dyslipidemia in the nephrotic syndrome. Physiopathological aspects and therapeutic prospects].
D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003918:Dextrothyroxine / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology*; D008074:Lipoproteins / Q000097:blood; D009404:Nephrotic Syndrome / Q000150:complications* / Q000188:drug therapy; D009539:Nicotinic Acids / Q000627:therapeutic use; D010743:Phospholipids / Q000097:blood / Q000627:therapeutic use; D014364:Tryptophan / Q000627:therapeutic use
D008074:Lipoproteins; D009539:Nicotinic Acids; D010743:Phospholipids; D002792:Cholestyramine Resin; D003918:Dextrothyroxine; D014364:Tryptophan; D002784:Cholesterol
La dislipidemia nella sindrome nefrosica. Aspetti fisiopatologici e prospettive terapeutiche